Thomas M Hennigan, the CFO of $CGBD, bought 7,285 shares of the company on 08-20-2025 for an estimated $100,168. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 9.0%. Following this trade, they now own 88,494 shares of this class of $CGBD stock.
$CGBD Insider Trading Activity
$CGBD insiders have traded $CGBD stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CGBD stock by insiders over the last 6 months:
- THOMAS M HENNIGAN (CFO) purchased 7,285 shares for an estimated $100,168
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGBD Hedge Fund Activity
We have seen 93 institutional investors add shares of $CGBD stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRIME CAPITAL INVESTMENT ADVISORS, LLC added 2,204,508 shares (+inf%) to their portfolio in Q2 2025, for an estimated $30,157,669
- CHOREO, LLC added 1,458,028 shares (+inf%) to their portfolio in Q2 2025, for an estimated $19,945,823
- VAN ECK ASSOCIATES CORP added 582,133 shares (+48.4%) to their portfolio in Q2 2025, for an estimated $7,963,579
- CLIFFWATER LLC added 548,617 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,505,080
- MARINER, LLC added 543,376 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,433,383
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 410,472 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,615,256
- LSV ASSET MANAGEMENT removed 395,526 shares (-31.5%) from their portfolio in Q2 2025, for an estimated $5,410,795
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGBD Analyst Ratings
Wall Street analysts have issued reports on $CGBD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 07/25/2025
- JP Morgan issued a "Underweight" rating on 04/24/2025
To track analyst ratings and price targets for $CGBD, check out Quiver Quantitative's $CGBD forecast page.
$CGBD Price Targets
Multiple analysts have issued price targets for $CGBD recently. We have seen 4 analysts offer price targets for $CGBD in the last 6 months, with a median target of $14.75.
Here are some recent targets:
- Bryce Rowe from B. Riley Securities set a target price of $14.5 on 08/11/2025
- Finian O'Shea from Wells Fargo set a target price of $15.0 on 07/25/2025
- Mitchel Penn from Oppenheimer set a target price of $15.0 on 05/08/2025
- Melissa Wedel from JP Morgan set a target price of $14.0 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
